Pliant Therapeutics Inc <PLRX.OQ> expected to post a loss of 70 cents a share - Earnings Preview
Pliant Therapeutics Inc PLRX.OQ PLRX.O is expected to show no change in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2025
LSEG's mean analyst estimate for Pliant Therapeutics Inc is for a loss of 70 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 11 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Pliant Therapeutics Inc is $3.00, about 51.3% above its last closing price of $1.46
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.71 | -0.72 | -0.92 | Missed | -27 |
Dec. 31 2025 | -0.98 | -0.98 | -0.82 | Beat | 16.6 |
Sep. 30 2024 | -0.96 | -0.97 | -0.95 | Beat | 2 |
Jun. 30 2024 | -0.83 | -0.85 | -0.92 | Missed | -8.4 |
Mar. 31 2024 | -0.75 | -0.77 | -0.78 | Missed | -1.1 |
Dec. 31 2023 | -0.77 | -0.81 | -0.69 | Beat | 15.2 |
Sep. 30 2023 | -0.76 | -0.77 | -0.70 | Beat | 9.7 |
Jun. 30 2023 | -0.72 | -0.71 | -0.70 | Beat | 1.9 |
This summary was machine generated August 1 at 11:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Investing in Industrials Stocks
TradingKey - Industrials are having a remarkable 2025 recovery, quietly but powerfully. No longer a defensively minded, yield-driven sector, they are riding waves of structural change from geopolitics and AI infrastructure to the great global supply chain reshore. While the S&P 500 continues to...
Amazon Q2 FY2025 Earnings Review: Robust Cloud and AI Growth Coupled with Retail Tariff Challenges
TradingKey - Amazon.com, Inc. (NASDAQ: AMZN) released its Q2 FY2025 earnings on July 31, 2025, after market close, delivering results that surpassed expectations, driven by robust growth in AWS, advertising, and retail segments.
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.
What Is Binance Coin (BNB), and Can It Really Hit $2,775 by 2028?
BNB is the native token of Binance, the world’s largest crypto exchange. Launched in 2017 via an ICO, BNB started as an ERC-20 token on Ethereum before migrating to BNB Chain, which includes both the Binance Smart Chain (BSC) and Binance Chain.
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics..jpg)
